NCT06000150 (Trachoma) is a clinical trial of Corneal topography in Corneal Opacity, sponsored by Omar Said.

Who is sponsoring NCT06000150?

NCT06000150 is sponsored by Omar Said.

What drugs are being tested in NCT06000150?

Interventions in NCT06000150: Corneal topography.

What condition does NCT06000150 study?

NCT06000150 studies Corneal Opacity.

Is NCT06000150 still recruiting?

NCT06000150 is currently completed. Last updated 21 August 2023.

Last reviewed 2023-08-21 · How we verify

NCT06000150: Trachoma

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Characteristics of Trachomatous Corneal Opacity in Fayoum University Hospital

Completed Last updated 21 August 2023

What this trial tests

trial testing Corneal topography in Corneal Opacity in 50 participants. Completed in 30 August 2022.

Timeline

1 February 2022

Primary endpoint
30 August 2022

30 August 2022

Quick facts

Lead sponsor	Omar Said
Status	Completed
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 February 2022
Primary completion	30 August 2022
Estimated completion	30 August 2022
Sites	1 location across Egypt

Drugs / interventions tested

Corneal topography

Conditions studied

Corneal Opacity — all drugs for Corneal Opacity →

Sponsor

Omar Said

Who can join

Eligibility, any sex, with Corneal Opacity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the characteristics of trachomatous corneal opacity in patients with signs of trachoma using Anterior segment Optic coherence tomography and Pentacam

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Corneal topography

Trials testing the same drug.

NCT06798779 — Predicting Manifest Astigmatism in Keratoconus Patients. · active not recruiting

Other recruiting trials for Corneal Opacity

Currently open trials in the same condition.

NCT06174376 — Clinical Outcomes of the Gore Synthetic Cornea Device · NA · recruiting
NCT03504800 — OCT in Diagnosis of Irregular Corneas · recruiting

Other Omar Said trials

Trials by the same sponsor.

NCT06000176 — Comparison of Optical Coherence Tomography Angiography Microvascular Changes in Primary Open Angle and Primary Angle Clo · completed
NCT06031350 — Peripapillary and Macular Vascular Changes of Unilateral Anterior Ischemic Optic Neuropathy: An Optical Coherence Tomogr · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06000150 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Omar Said
Last refreshed: 21 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06000150.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing